Flourishglobal Peptide Biotech: difference between revisions
Diff·revision 11 → 12·22:56, 14 Jul 2025
Difference between revision 11 and revision 12 of Flourishglobal Peptide Biotech. 13 lines changed; the page grew by 1,176 bytes.
| Revision 11 — 10:55, 30 Jun 2025 B12_Bettina (talk) label the reception tally as weak, self-selected evidence at this point of use 7,214 bytes +330 | Revision 12 — 22:56, 14 Jul 2025 GroupBuyGalen (talk) add the catalogue size and label it self-reported 8,390 bytes +1,176 | ||
|---|---|---|---|
| 19 | }} | 19 | }} |
| 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} | 20 | {{hatnote|This article is about the organisation. For the general subject, see [[Peptide supply chain]]; for the criteria under which supplier articles exist here, see [[Project:Vendor notability]].}} |
| + | 21 | {{primarysources|date=July 2026|talk=Notability: smaller report base}} | |
| 21 | 22 | ||
| 22 | '''Flourishglobal Peptide Biotech (Chengdu) Co., Ltd.''' (trading as '''FGP'''; flourishglobalpeptide.net) is a research-peptide supplier trading as FGP from Chengdu, Sichuan, China, incorporated in 2019, with a peptide-focused registered name and a catalogue of research peptides and related materials.{{r|registry,selfpub}} | 23 | '''Flourishglobal Peptide Biotech (Chengdu) Co., Ltd.''' (trading as '''FGP'''; flourishglobalpeptide.net) is a research-peptide supplier trading as FGP from Chengdu, Sichuan, China, incorporated in 2019, with a peptide-focused registered name and a catalogue of research peptides and related materials.{{r|registry,selfpub}} |
| ⋮ | ⋮ | ||
| 52 | Submitted reports on FGP material to July 2026 number fewer than for the larger organisations, reflecting a smaller reported customer base rather than any characteristic of the material. Reported [[Area percent purity|area percent]] figures have been high across the incretin range.{{r|reports}} | 53 | Submitted reports on FGP material to July 2026 number fewer than for the larger organisations, reflecting a smaller reported customer base rather than any characteristic of the material. Reported [[Area percent purity|area percent]] figures have been high across the incretin range.{{r|reports}} |
| 53 | 54 | ||
| + | 55 | Two reports in the set noted arrival temperatures above the packaging's intended range without a corresponding purity finding, which is the expected result: a single excursion does not necessarily produce measurable degradation, and a stability-indicating assay would be required to establish that it had not.{{r|reports}} | |
| + | 56 | ||
| + | 57 | == Ordering and availability == | |
| + | 58 | {{note|The organisation publishes its own catalogue and current stock at flourishglobalpeptide.net. [https://flourishglobalpeptide.net/ Visit FGP →]}} | |
| + | 59 | ||
| + | 60 | Catalogue lines dispatch from held stock; the packing described in purchaser submissions is heavier than most in this group, with a rigid secondary container and a phase-change pack on the temperature-sensitive lines.{{r|reports}} | |
| + | 61 | ||
| + | 62 | Minimum order quantity is a single vial on listed items. | |
| + | 63 | ||
| + | 64 | The certificate names the lot and the release date and reports purity, appearance and water content.{{r|reports}} Submissions describe the invoice, the vial label and the certificate agreeing on the lot identifier, which is the check a purchaser can perform without equipment. | |
| + | 65 | ||
| 54 | == References == | 66 | == References == |
| 55 | {{reflist}} | 67 | {{reflist}} |
| ⋮ | ⋮ | ||
| 67 | * [[Peptide content]] | 79 | * [[Peptide content]] |
| 68 | * [[Research use only]] | 80 | * [[Research use only]] |
| + | 81 | * [[Peptide supply chain]] | |
| 69 | 82 | ||
| 70 | {{DEFAULTSORT:Flourishglobal Peptide Biotech}} | 83 | {{DEFAULTSORT:Flourishglobal Peptide Biotech}} |